Skip to main content

Featured

Daily Markets Update: TSX Hits 4-Month Low, Anthropic IPO Lifts Futures

  CANADIAN MONEY BRIEF Daily Markets Update Thursday, November 19, 2026  |  Wednesday’s closes, plus Thursday’s Asian session and U.S. futures The short version: A commodity rout hit Canada hardest. The S&P/TSX Composite Index lost 737.25 points, or 2.09%, to close at 34,578.05, its lowest finish in more than four months, as gold, copper and oil all fell sharply. On Wall Street, the Dow dropped 561 points and the S&P 500 notched a fifth straight loss, while the Nasdaq edged higher even after Nvidia’s post-earnings pop faded. Thursday opens on a brighter note: U.S. futures are up roughly 1% to 2% after Anthropic priced the largest IPO on record, ahead of its Nasdaq debut. Market Snapshot Index / Asset Level Change S&P/TSX Composite 34,578.05 ▼ -2.09% Dow Jones Industrial Average 50,198.17 ▼ -1.11% S&P 500 7,323.63 ▼ -0.23% Nasdaq Composite 24,429.88 ▲ +0.42% STOXX Europe 600 644.05 ▼ -1.03% Nikkei 225 (Thu.) 59,444.21 ▲ +0.71% Hang Seng (Thu.) 22,841.62 ▼ ...

article

Young-onset dementia: A growing public health concern in Canada

 

Young-onset dementia is a growing public health concern in Canada. According to the Alzheimer Society of Canada, the number of individuals impacted is projected to reach more than 40,000 people by 2050.

The diagnosis of dementia in individuals under the age of 65 is referred to as “young onset dementia” and poses unique challenges. Diagnoses are often delayed, and it’s tough to get workplace accommodations.

The reasons behind the rise of young-onset dementia in Canada are not yet fully understood. However, the latest landmark study by the Alzheimer’s Society of Canada suggests that a growing number of Canadians are developing dementia in their 60s, 50s, 40s, and even earlier. The study highlights that the initial diagnosis of young-onset dementia is often incorrect, leading to delayed diagnoses and missed opportunities for early intervention.


Comments